Po‐Len Liu

3.5k total citations
79 papers, 2.8k citations indexed

About

Po‐Len Liu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Po‐Len Liu has authored 79 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Surgery. Recurrent topics in Po‐Len Liu's work include Inflammasome and immune disorders (8 papers), Magnolia and Illicium research (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Po‐Len Liu is often cited by papers focused on Inflammasome and immune disorders (8 papers), Magnolia and Illicium research (7 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Po‐Len Liu collaborates with scholars based in Taiwan, China and Japan. Po‐Len Liu's co-authors include Yung‐Hsiang Chen, Yuh‐Lien Chen, Chia‐Yang Li, Shing‐Jong Lin, Po‐Hsun Huang, Feng‐Yen Lin, Inn‐Wen Chong, Shu‐Chi Wang, Jaw‐Wen Chen and Jong‐Rung Tsai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Po‐Len Liu

76 papers receiving 2.7k citations

Peers

Countries citing papers authored by Po‐Len Liu

Since Specialization

Citations

This map shows the geographic impact of Po‐Len Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Len Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Len Liu more than expected).

Fields of papers citing papers by Po‐Len Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Len Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Len Liu. The network helps show where Po‐Len Liu may publish in the future.

Co-authorship network of co-authors of Po‐Len Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Len Liu. A scholar is included among the top collaborators of Po‐Len Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Len Liu. Po‐Len Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plumbagin improves pulmonary vascular remodeling in PAH via miR-21-5p/MMP/TIMP regulation, with diagnostic implications for cardiac function 2025 ·Biomedicine & Pharmacotherapy ·Chong‐Chao Hsieh, Hsuan‐Fu Kuo, (unknown), (unknown), I‐Ling Chen, (unknown), Yi‐Ching Lo, Zi-Jing Lin, Yung‐Hsiang Chen, Yur‐Ren Kuo, Chih‐Hsin Hsu, Po‐Len Liu	0
2	Magnolol facilitates mitochondrial-peroxisome dysfunction and induces oxeiptosis in lung cancer cells following transfer via tunneling nanotubes 2025 ·Biomedicine & Pharmacotherapy ·Meng‐Hsuan Cheng, (unknown), (unknown), (unknown), Zi-Jing Lin, (unknown), Chih‐Hsin Hsu, Chia‐Yang Li, Shu‐Chi Wang, Yung‐Hsiang Chen, (unknown), Wei‐Lun Liu, Po‐Len Liu	6
3	Protective effects of nordalbergin against LPS-induced endotoxemia through inhibiting MAPK/NF-κB signaling pathway, NLRP3 inflammasome activation, and ROS production 2024 ·Inflammation Research ·(unknown), Chia‐Yang Li, (unknown), I‐Chen Chen, Po‐Len Liu, Yi‐Ting Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wei‐Chung Cheng, Chien‐Chih Chiu, (unknown), Shu‐Chi Wang	3
4	Nordalbergin Exerts Anti-Neuroinflammatory Effects by Attenuating MAPK Signaling Pathway, NLRP3 Inflammasome Activation and ROS Production in LPS-Stimulated BV2 Microglia 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Kun‐Che Chang, Po‐Yen Lee, Po‐Len Liu, Shu‐Pin Huang, Pei‐Chang Wu, (unknown), Yu‐Hung Lai, (unknown), (unknown), (unknown), (unknown), Shu‐Chi Wang, Chia‐Yang Li	12
5	Kurarinone exerts anti-inflammatory effect via reducing ROS production, suppressing NLRP3 inflammasome, and protecting against LPS-induced sepsis 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Po‐Yen Lee, (unknown), I‐Chen Chen, Po‐Len Liu, (unknown), (unknown), Yi‐Ting Chen, Shu‐Pin Huang, Hsin‐Chih Yeh, (unknown), (unknown), (unknown), Shu‐Chi Wang, Chia‐Yang Li	14
6	Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway 2023 ·The American Journal of Chinese Medicine ·(unknown), Chia‐Cheng Su, Shu‐Chi Wang, Po‐Len Liu, Wei‐Chung Cheng, Hsin‐Chih Yeh, Chih‐Pin Chuu, Jen‐Kun Chen, Bo‐Ying Bao, (unknown), Chien‐Chih Ke, (unknown), (unknown), Shu‐Pin Huang, Chia‐Yang Li	4
7	Scrotal Pain after Varicocelectomy: A Narrative Review 2023 ·Biomedicines ·(unknown), Szu‐Ju Chen, Chi‐Ping Huang, Huey‐Yi Chen, Ming-Yen Tsai, Po‐Len Liu, Yung‐Hsiang Chen, Wen‐Chi Chen	2
8	Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation 2022 ·Journal of Inflammation Research ·(unknown), (unknown), (unknown), Po‐Yen Lee, Po‐Len Liu, Pei‐Chang Wu, (unknown), Chi‐Shuo Chen, Chien‐Chih Chiu, Yu‐Hung Lai, Yo‐Chen Chang, (unknown), (unknown), (unknown), Shu‐Pin Huang, Shu‐Chi Wang, Chia‐Yang Li	28
9	Magnolol regulates miR-200c-3p to inhibit epithelial–mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo 2022 ·Phytomedicine ·Yu‐Hung Lai, Wei‐Lun Liu, Tsung‐Ying Lee, Chung-Wen Kuo, Yuru Liu, (unknown), Yung‐Hsiang Chen, I‐Ling Chen, (unknown), Shu‐Chi Wang, Po‐Yen Lee, (unknown), (unknown), Yo‐Chen Chang, Hsuan‐Fu Kuo, Chong‐Chao Hsieh, Chia‐Yang Li, Po‐Len Liu	5
10	Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer 2022 ·European Journal of Pharmacology ·Hsin‐Chih Yeh, Chia‐Cheng Su, (unknown), (unknown), Bo‐Ying Bao, Wei‐Chung Cheng, Shu‐Chi Wang, Po‐Len Liu, Chien‐Chih Chiu, Chih‐Pin Chuu, Chien‐Chih Ke, (unknown), (unknown), (unknown), Shu‐Pin Huang, Chia‐Yang Li	2
11	Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation 2021 ·Pharmaceuticals ·(unknown), Shu‐Chi Wang, I‐Chen Chen, Yi‐Ting Chen, Po‐Len Liu, Shih‐Hua Fang, Shu‐Pin Huang, Hsin‐Chih Yeh, (unknown), Po‐Yen Lee, (unknown), Wei‐Chung Cheng, Chia‐Cheng Su, (unknown), (unknown), Chia‐Yang Li	27
12	Mycotoxin Zearalenone Attenuates Innate Immune Responses and Suppresses NLRP3 Inflammasome Activation in LPS-Activated Macrophages 2021 ·Toxins ·Po‐Yen Lee, (unknown), Shu‐Chi Wang, (unknown), (unknown), Po‐Len Liu, Chien‐Chih Chiu, I‐Chen Chen, Yu‐Hung Lai, Wei‐Chung Cheng, (unknown), Hsin‐Chih Yeh, (unknown), Chia‐Cheng Su, Shu‐Pin Huang, Chia‐Yang Li	17
13	AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway 2019 ·International Journal of Molecular Sciences ·Chia‐Cheng Su, (unknown), Po‐Len Liu, Hsin‐Chih Yeh, Shu‐Pin Huang, Shih‐Hua Fang, Wei‐Chung Cheng, Kuan‐Hua Huang, (unknown), I‐Ling Lin, Ming‐Yii Huang, Chia‐Yang Li	54
14	Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia 2018 ·BMC Complementary and Alternative Medicine ·Ming‐Yii Huang, (unknown), Shu‐Chi Wang, (unknown), Chia‐Cheng Su, Shih‐Hua Fang, Chi‐Shuo Chen, Po‐Len Liu, Wei‐Chung Cheng, Yuwei Huang, Chia‐Yang Li	66
15	RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment 2018 ·Scientific Reports ·(unknown), (unknown), Wei‐Chung Cheng, Shu‐Chi Wang, Shih‐Hua Fang, Hung‐Pin Tu, Chia‐Cheng Su, (unknown), Po‐Len Liu, Chi‐Shuo Chen, Yuting Wang, Chia‐Yang Li	37
16	Synthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cells 2014 ·Journal of Colloid and Interface Science ·Chau‐Zen Wang, Yin‐Chih Fu, (unknown), Yan‐Hsiung Wang, Po‐Len Liu, Mei‐Ling Ho, Chih‐Kuang Wang	40
17	Biofunctional Constituents from Liriodendron tulipifera with Antioxidants and Anti-Melanogenic Properties 2013 ·International Journal of Molecular Sciences ·Wei‐Jen Li, (unknown), Pei‐Fang Wu, Zhi‐Hong Wen, Po‐Len Liu, Chung‐Yi Chen, Huimin Wang	28
18	Intraocular Pressure-Lowering Effect of Auricular Acupressure in Patients with Glaucoma: A Prospective, Single-Blinded, Randomized Controlled Trial 2010 ·The Journal of Alternative and Complementary Medicine ·(unknown), Po‐Len Liu, (unknown), (unknown), Po‐Hsun Huang, Yuh‐Lien Chen, Chih-Pei Lin, (unknown), (unknown), (unknown), (unknown), (unknown), Jui‐Lung Shen, Wen‐Chi Chen, Yung‐Hsiang Chen	19
19	Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancer 2010 ·Molecular Carcinogenesis ·Po‐Len Liu, Jong‐Rung Tsai, Chien‐Chih Chiu, Jhi‐Jhu Hwang, Shah‐Hwa Chou, Chih‐Kuang Wang, (unknown), Yuh‐Lien Chen, Wen‐Chi Chen, Yung‐Hsiang Chen, Inn‐Wen Chong	42
20	Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1‐mediated nuclear factor‐κB pathway and subsequently downregulating expression of matrix metalloproteinases 2010 ·Molecular Nutrition & Food Research ·Po‐Len Liu, Jong‐Rung Tsai, Albert Linton Charles, Jhi‐Jhu Hwang, Shah‐Hwa Chou, Yueh‐Hsin Ping, Feng‐Yen Lin, Yuh‐Lien Chen, (unknown), Wen‐Chi Chen, (unknown), (unknown), Inn‐Wen Chong	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact